Biotech Values

[winchem21]

MUCIN SYNTHESIS INHIBITORS Patent Application Pub Dec 25, 2003.
20030236220

This is the first info I have found on the chloride channel mucous inhibitors that Levitt has been discussing since the November WSJ interview. Apparently they initially filed this in Nov 2002 and the application was just posted on the USPTO.

Here is the abstract:
"The claimed invention relates to methods of modulating mucin synthesis and the therapeutic application of compounds in controlling mucin over-production associated with diseases such as chronic obstructive pulmonary diseases (COPD) including asthma and chronic bronchitis, inflammatory lung diseases, cystic fibrosis and acute or chronic respiratory infectious diseases."

Levitt has been predicting obtaining IP on this in '04 and licensing it to big pharma; apparently a number of companies are already investigating this target.

wc21